Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Adaptimmune Therapeutics
ADAP

Buy Adaptimmune Therapeutics (ADAP) Stock

ADAP
See ADAP stock price and Buy/Sell Adaptimmune Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
ADAP

Adaptimmune Therapeutics (ADAP)

About Adaptimmune Therapeutics (ADAP)

Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom...Read more
Market Cap
$195.36M
1 Year High
$5.95
Volume
1 Year Low
$1.10
Price to Earnings Ratio
Open
$1.16
Dividend Rate
High
$1.24
Dividend Yield
Low
$1.16

Community

People who own or watch ADAP stock

Adaptimmune Therapeutics Price Targets

What analysts think ADAP stock price will be.
$1.20
$6
400.0% Upside
$1$7

Adaptimmune Therapeutics Stock Rating

What analysts recommend for ADAP stock, on a scale from 1(buy) to 5(sell).
Hold2.7 / 5
BuyHoldSell

Adaptimmune Therapeutics Stock Earnings

The value each ADAP share was expected to gain vs. the value that each ADAP share actually gained.
Expected
Actual

Adaptimmune Therapeutics Stock News

Themes

Explore other stocks like ADAP in these curated Themes.
Fighting Disease

Frequently Asked Questions (FAQ)

As of Sep 26, 2022, the market cap for ADAP stock is $195.36M

The 52-week high for ADAP stock is $5.95. The current ADAP stock price $1.2 is 79.83% below its 52-week high

The 52-week low for ADAP stock is $1.10. The current ADAP stock price $1.2 has increased 8.33% from its 52-week low

No, the ADAP stock does not pay dividends to its shareholders

The target price for ADAP stock is $6 based on the average of what a group of analyst think ADAP stock could be worth at a future date. This is not a prediction by Public.com

Buy Adaptimmune Therapeutics (ADAP) Stock

ADAP
See ADAP stock price and Buy/Sell Adaptimmune Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch ADAP stock
  • Eyebrows avatar
  • phillyfame19 avatar
  • wisdom177 avatar
  • mollyisland avatar
  • bmwilli2 avatar

Themes

Explore other stocks like ADAP in these curated Themes.
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.